Lv5
966 积分 2024-08-20 加入
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial
5个月前
已完结
GDF-15 in Cardiovascular Disease
7个月前
已关闭
The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab
7个月前
已完结
The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab
7个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
7个月前
已完结
皖公网安备34019202002308
